A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high‐titer ABO antibodies
Karen Quillen(Boston University), Willy A. Flegel(National Institutes of Health Clinical Center), Jennifer A. Daniel‐Johnson(Boston University), A. Hallie Lee‐Stroka(Boston University), Sherry L. Sheldon(National Institutes of Health Clinical Center)
Cited by 71
Related Papers
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Molecular Basis of Weak D Phenotypes
|Blood|1999|336
Molecular Basis of Weak D Phenotypes
|Blood|1999|331
RHD gene deletion occurred in the Rhesus box
|Blood|2000|319
RHD positive haplotypes in D negative Europeans
|BMC Genetics|2001|310